BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bonella F, Stowasser S, Wollin L. Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib. Drug Des Devel Ther 2015;9:6407-19. [PMID: 26715838 DOI: 10.2147/DDDT.S76648] [Cited by in Crossref: 13] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Goertsen D, Goeden N, Flytzanis NC, Gradinaru V. Targeting the lung epithelium after intravenous delivery by directed evolution of underexplored sites on the AAV capsid. Mol Ther Methods Clin Dev 2022;26:331-42. [PMID: 35990749 DOI: 10.1016/j.omtm.2022.07.010] [Reference Citation Analysis]
2 Colunga Biancatelli RML, Solopov PA, Catravas JD. The Inflammasome NLR Family Pyrin Domain-Containing Protein 3 (NLRP3) as a Novel Therapeutic Target for Idiopathic Pulmonary Fibrosis. Am J Pathol 2022;192:837-46. [PMID: 35351468 DOI: 10.1016/j.ajpath.2022.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Panahi L, Udeani G, Scott Tenpas A, Ofili T, Marie Aguilar E, Burchard S, Ruth Ritenour A, Jacob Chennat A, Ahmed N, Atphaisit C, Chi C, Cruz Iii J, D. Deleon M, Lee S, Mayo Z, Mcbeth M, Morales M, N. Nwosu J, Palacios K, M. Pena J, Vara N. Pharmacological Management of Idiopathic Pulmonary Fibrosis. Idiopathic Pulmonary Fibrosis [Working Title] 2021. [DOI: 10.5772/intechopen.101390] [Reference Citation Analysis]
4 Arndt S, Unger P, Bosserhoff AK, Berneburg M, Karrer S. The Anti-Fibrotic Effect of Cold Atmospheric Plasma on Localized Scleroderma In Vitro and In Vivo. Biomedicines 2021;9:1545. [PMID: 34829774 DOI: 10.3390/biomedicines9111545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Doubkova M, Kriegova E, Littnerova S, Schneiderova P, Sterclova M, Bartos V, Plackova M, Zurkova M, Bittenglova R, Lostaková V, Siskova L, Lisa P, Suldova H, Doubek M, Psikalova J, Snizek T, Musilova P, Vasakova M. DSP rs2076295 variants influence nintedanib and pirfenidone outcomes in idiopathic pulmonary fibrosis: a pilot study. Ther Adv Respir Dis 2021;15:17534666211042529. [PMID: 34515605 DOI: 10.1177/17534666211042529] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Diazzi S, Baeri A, Fassy J, Lecacheur M, Marin-bejar O, Girard C, Lefevre L, Lacoux C, Irondelle M, Mounier C, Truchi M, Couralet M, Carminati A, Berestjuk I, Larbret F, Vassaux G, Marine J, Deckert M, Mari B, Tartare-deckert S. Blockade of pro-fibrotic response mediated by the miR-143/-145 cluster prevents targeted therapy-induced phenotypic plasticity and resistance in melanoma.. [DOI: 10.1101/2021.07.02.450838] [Reference Citation Analysis]
7 Goplen NP, Cheon IS, Sun J. Age-Related Dynamics of Lung-Resident Memory CD8+ T Cells in the Age of COVID-19. Front Immunol 2021;12:636118. [PMID: 33854506 DOI: 10.3389/fimmu.2021.636118] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
8 Kawara A, Mizuta R, Fujisawa M, Ito T, Li C, Nakamura K, Sun C, Kuwabara M, Kitabatake M, Yoshimura T, Matsukawa A. Spred2-deficiency enhances the proliferation of lung epithelial cells and alleviates pulmonary fibrosis induced by bleomycin. Sci Rep 2020;10:16490. [PMID: 33020583 DOI: 10.1038/s41598-020-73752-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
9 Ho L, Yip A, Lao F, Botelho F, Richards CD. RELMα is Induced in Airway Epithelial Cells by Oncostatin M Without Requirement of STAT6 or IL-6 in Mouse Lungs In Vivo. Cells 2020;9:E1338. [PMID: 32471168 DOI: 10.3390/cells9061338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Armesto-jimenez AU, Arason AJ, Stefansson OA, Gudmundsson G, Gudjonsson T, Magnusson MK. A MUC5B polymorphism associated with Idiopathic Pulmonary Fibrosis mediates overexpression through decreased CpG methylation and C/EBPβ transcriptional activation.. [DOI: 10.1101/2019.12.18.880674] [Reference Citation Analysis]
11 McLean-Tooke A, Moore I, Lake F. Idiopathic and immune-related pulmonary fibrosis: diagnostic and therapeutic challenges. Clin Transl Immunology 2019;8:e1086. [PMID: 31709050 DOI: 10.1002/cti2.1086] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
12 Asmani M, Kotei C, Hsia I, Marecki L, Wang T, Zhou C, Zhao R. Cyclic Stretching of Fibrotic Microtissue Array for Evaluation of Anti-Fibrosis Drugs. Cell Mol Bioeng 2019;12:529-40. [PMID: 31719931 DOI: 10.1007/s12195-019-00590-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
13 Barnes JW, Duncan D, Helton S, Hutcheson S, Kurundkar D, Logsdon NJ, Locy M, Garth J, Denson R, Farver C, Vo HT, King G, Kentrup D, Faul C, Kulkarni T, De Andrade JA, Yu Z, Matalon S, Thannickal VJ, Krick S. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2019;317:L141-54. [PMID: 31042083 DOI: 10.1152/ajplung.00246.2018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
14 Shamskhou EA, Kratochvil MJ, Orcholski ME, Nagy N, Kaber G, Steen E, Balaji S, Yuan K, Keswani S, Danielson B, Gao M, Medina C, Nathan A, Chakraborty A, Bollyky PL, De Jesus Perez VA. Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice. Biomaterials 2019;203:52-62. [PMID: 30852423 DOI: 10.1016/j.biomaterials.2019.02.017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 13.7] [Reference Citation Analysis]
15 Zeinali S, Bichsel CA, Hobi N, Funke M, Marti TM, Schmid RA, Guenat OT, Geiser T. Human microvasculature-on-a chip: anti-neovasculogenic effect of nintedanib in vitro. Angiogenesis 2018;21:861-71. [PMID: 29967964 DOI: 10.1007/s10456-018-9631-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
16 Gocht A, Spriewald B, Distler JHW, Ramsperger-Gleixner M, Ensminger SM, Weyand M, Heim C. Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts. Transplant Direct 2018;4:e367. [PMID: 30046657 DOI: 10.1097/TXD.0000000000000804] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
17 Hajari Case A, Johnson P. Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis. BMJ Open Respir Res 2017;4:e000192. [PMID: 28883926 DOI: 10.1136/bmjresp-2017-000192] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
18 Kubo N, Araki K, Yamanaka T, Hoshino K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Hirai K, Saitoh F, Kuwano H, Shirabe K. Perioperative management of hepatectomy in patients with interstitial pneumonia: a report of three cases and a literature review. Surg Today 2017;47:1173-9. [PMID: 28251374 DOI: 10.1007/s00595-017-1489-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
19 Guan R, Wang X, Zhao X, Song N, Zhu J, Wang J, Wang J, Xia C, Chen Y, Zhu D. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation. Sci Rep. 2016;6:35696. [PMID: 27774992 DOI: 10.1038/srep35696] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 6.8] [Reference Citation Analysis]
20 Ebenezer DL, Fu P, Natarajan V. Targeting sphingosine-1-phosphate signaling in lung diseases. Pharmacol Ther 2016;168:143-57. [PMID: 27621206 DOI: 10.1016/j.pharmthera.2016.09.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
21 Kimura T, Nojiri T, Hino J, Hosoda H, Miura K, Shintani Y, Inoue M, Zenitani M, Takabatake H, Miyazato M, Okumura M, Kangawa K. C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice. Respir Res 2016;17:19. [PMID: 26895702 DOI: 10.1186/s12931-016-0335-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]